- Home
- SPPP vs DERM Comparison
SPPP vs DERM Comparison
Compare SPPP & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPPP
- DERM
- Stock Information
- Founded
- SPPP 2011
- DERM 2014
- Country
- SPPP Canada
- DERM United States
- Employees
- SPPP N/A
- DERM N/A
- Industry
- SPPP
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- SPPP
- DERM Health Care
- Exchange
- SPPP NYSE
- DERM Nasdaq
- Market Cap
- SPPP 140.9M
- DERM 140.0M
- IPO Year
- SPPP N/A
- DERM 2021
- Fundamental
- Price
- SPPP $9.51
- DERM $6.25
- Analyst Decision
- SPPP
- DERM Strong Buy
- Analyst Count
- SPPP 0
- DERM 2
- Target Price
- SPPP N/A
- DERM $10.00
- AVG Volume (30 Days)
- SPPP 183.3K
- DERM 103.6K
- Earning Date
- SPPP 01-01-0001
- DERM 05-12-2025
- Dividend Yield
- SPPP N/A
- DERM N/A
- EPS Growth
- SPPP N/A
- DERM N/A
- EPS
- SPPP N/A
- DERM N/A
- Revenue
- SPPP N/A
- DERM $56,134,000.00
- Revenue This Year
- SPPP N/A
- DERM $29.83
- Revenue Next Year
- SPPP N/A
- DERM $54.88
- P/E Ratio
- SPPP N/A
- DERM N/A
- Revenue Growth
- SPPP N/A
- DERM N/A
- 52 Week Low
- SPPP $8.55
- DERM $3.20
- 52 Week High
- SPPP $11.39
- DERM $7.29
- Technical
- Relative Strength Index (RSI)
- SPPP 51.39
- DERM 53.65
- Support Level
- SPPP $9.01
- DERM $5.98
- Resistance Level
- SPPP $9.69
- DERM $6.40
- Average True Range (ATR)
- SPPP 0.14
- DERM 0.62
- MACD
- SPPP 0.02
- DERM -0.06
- Stochastic Oscillator
- SPPP 58.25
- DERM 36.97
About SPPP SPROTT PHYS PLATINUM & PALLADIUM
Sprott Physical Platinum & Palladium Tr invests and holds all of its assets in physical platinum and palladium bullion. The company seeks to provide a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical platinum and palladium bullion without the inconvenience that is typical of a direct investment in physical bullion. The Trust invests mainly in long-term holdings of unencumbered, fully allocated, physical platinum and palladium bullion.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.